Results 11 to 20 of about 5,843 (268)

Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity. [PDF]

Sci Rep, 2017
AbstractThe present study, we design and synthesize the novel dihydropyridine derivatives, i.e., 3 (a-e) and 5 (a-e) and evaluated, anticonvulsant activity. Initially due to the lacuna of LCC, we modeled the protein through modeller 9.15v and evaluated through servers.
Saddala MS, Kandimalla R, Adi PJ, Bhashyam SS, Asupatri UR.   +4 more
europepmc   +7 more sources

Synthesis of 1, 4-Dihydropyridine Derivatives using FeCl3 as Catalyst under Solvent-free Condition

Oriental Journal Of Chemistry, 2013
Chemistry of dihydropyridines in 1882 with Ar thur Hansh reports the β-keto ester, aldehydes and ammonia can be combined to form 1, 4-dihydropyridine was developed. Because of the many benefits of 1, 4-dihydropridine is presented and now as vital medicines to treat angina, high blood pressure and allergies have been introduced.
ABDORRAHMAN KEYHANI, Farhad Hatamjafari
openalex   +2 more sources

QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR) [PDF]

, 2016
Quantitative structure–activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors. A data set consisted of 72 compounds was selected, and then different types of
Aalizadeh, Reza, Avval, Zhila Mohajeri, Bostanifar, Mohammad Hassan, Khanzadeh, Marziyeh, Mozaffari, Shahla, Pourbasheer, Eslam, Rafiei, Hamid   +6 more
core   +1 more source

5-Oxo-hexahydroquinoline derivatives and their tetrahydroquinoline counterparts as multidrug resistance reversal agents [PDF]

, 2020
Cancer is a leading cause of death worldwide. Multidrug resistance (MDR) is a main reason of chemotherapy failure in many patients and is often related to overexpression of ATP-binding cassette (ABC) transporters, including P-glycoprotein (P-gp/ABCB1).
Dehghani, Mojtaba, Edraki, Najmeh, Firuzi, Omidreza, Khoshneviszadeh, Mehdi, Mohabbati, Maryam, Saso, Luciano, Shahraki, Omolbanin, Tavakkoli, Marjan   +7 more
core   +1 more source

New synthetic method for the synthesis of 1,4-dihydropyridine using aminated multiwalled carbon nanotubes as high efficient catalyst and investigation of their antimicrobial properties

Journal of Saudi Chemical Society, 2018
Synthesis of 1,4-dihydropyridines in the presence of aminated multiwalled carbon nanotubes and investigation into their antimicrobial properties were carried out.Amino functionalized carbon nanotubes were prepared through a facile, clean and safe ...
Roya Mahinpour, Leila Moradi, Zohreh Zahraei, Nafiseh Pahlevanzadeh   +3 more
doaj   +1 more source

Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators [PDF]

, 2004
A major problem in cancer treatment is the development of resistance to multiple chemotherapeutic agents in tumor cells. A major mechanism of this multidrug resistance (MDR) is overexpression of the MDR1 product P-glycoprotein, known to bind to and ...
Safa, Ahmad R.
core   +1 more source

1,1′-{[3,5-Bis(dodecyloxycarbonyl)-4-(naphthalen-2-yl)-1,4-dihydropyridine-2,6-diyl]bis(methylene)}bis{4-[(E)-2-(naphthalen-2-yl)vinyl]pyridin-1-ium}dibromide [PDF]

, 2022
Funding Information: Funding: This research was funded by the EuroNanoMed3 project TENTACLES No ES RTD/2020/18. Publisher Copyright: © 2022 by the authors.
Kaukulis, Martins, Pajuste, Karlis, Pikun, Nadiia, Plotniece, Aiva, Rucins, Martins, Sobolev, Arkadij   +5 more
core   +1 more source

PHOTODEGRADATION OF 1, 4-DIHYDROPYRIDINE ANTIHYPERTENSIVE DRUGS: AN UPDATED REVIEW

International Journal of Pharmacy and Pharmaceutical Sciences, 2018
1, 4-dihydropyridine calcium channels blockers (DHPs) are the most commonly used antihypertensive drugs. Unfortunately, these compounds have a significant degradability to light. The oxidation to the pyridine derivative represents the first, and in many cases the only, step of the degradation mechanism.
MICHELE DE LUCA, GIUSEPPINA IOELE, CLAUDIA SPATARI, GAETANO RAGNO   +3 more
openaire   +4 more sources

TiCl2/Nano-γ-Al2O3 as a Novel Lewis Acid Catalyst for Promotion of One-pot Synthesis of 1,4-dihydropyridines [PDF]

Journal of Nanostructures, 2018
Synthesis of organic compounds using nano-catalysts is more and more attention due to the numerous advantages such as cost-effectiveness, high catalytic activity, ease of product separation, recovery of the catalyst, repeated recycling potential and good
Bi Bi Fatemeh Mirjalili, Abdolhamid Bamoniri, Leila Asadollah Salmanpoor   +2 more
doaj   +1 more source

Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana) [PDF]

, 2017
Infectious diseases remain a significant threat to human health, contributing to more than 17 million deaths, annually. With the worsening trends of drug resistance, there is a need for newer and more powerful antimicrobial agents.
A Brüning, A Fodor, A Husain, A Idhayadhulla, A Kaplan, A Nemeikaitė-Čėnienė, A Pantosti, A Pawellek, A Rauf, A Richters, A Rico, A Sakunphueak, AJ Alanis, AM Alanazi, AM Carvalho, AM Griggs, AS Mayhoub, Ayaz Anwar, B Combourieu, B Sadek, B Villemagne, B Zarzycka, BE Bilich, BE Brown, BL Ginsborg, BV Le, C Amutha, C Rademacher, C Shiota, CA Morgan, CH Yen, CL Yuan, CMM Gómez, CT Makowski, D Duś, D Mehetre, D Raffa, D Vergara, DA Pisanenko, DJ Hardick, DT Youssef, E Braud, E Clynen, E Oberbauer, E Pery, E Rosatelli, EA Musad, EC Kormann, EM Flefel, EV Verbitskiy, F Puig-Basagoiti, FN Alvarez, FT Hatch, FZ Mharti, G Devasahayam, G Engelsma, G Liu, G Ramdani, G Ren, G Schlewer, G Şahin, GN Vassilev, H Chikhale, H Hatano, H Hussain, H Istanbullu, H Li, H Niaz, H Smetana, H Wang, HB Shin, HY Chen, I Karakaya, I Orhan, IC Zampini, J Győrfi, J Han, J La, J Mareddy, JD Guzman, JF Sun, JL Vennerstrom, JM Ontoria, JP Rappai, JR Bauquier, JW Weaver, JY Yang, K Iwasa, K Philip, K Tangdenpaisal, K Wada, KW Leal, KW Park, L Sun, LJ Huang, M Akhter, M al-Rashida, M Amiche, M Brunskole Švegelj, M Gökce, M Jahangir, M Ma, M Miyazawa, M Pawelczap, M Sagheer, M Salzet, M Zhu, MA Aziz-ur-Rehman Abbasi, MA Orabi, MC Enright, MD Bachi, MH Metz-Boutigue, MIC De Troconis, MJ Arrowood, MJ Frederico, MM Alam, MM Khafagy, MN Zemtsova, MT Mackmull, Muhammad Raza Shah, N Desplaces, N Mashhoon, N Sunduru, N Özbek, NA Khan, NA Khan, NA Lack, Naveed Ahmed Khan, ND Eddington, NG Anthony, NK Roy, NR Gonewar, O Perwitasari, OO Ajani, OO Peter, P Armati, P Bulet, P Chen, P Deprez, P Funk, P Kumar, P Nordmann, P Samadhiya, PB Savage, Peter J. Heard, PL Taylor, Q Zheng, QC Fu, R Bonnett, R Bonnett, R De Simone, R Ruckli, R Wilson, RA Tapia, RL Groves, Ruqaiyyah Siddiqui, S Antoniou, S Bondock, S Celikler, S Cesarini, S Elliott, S Ganguli, S George, S Indumathi, S Kasai, S Lee, S Minami, S Nagarajan, S Wirth, S Yang, SA Lujan, Salwa Mansur Ali, SC Bang, SC Basak, Seng-Kai Ong, SF Liou, SM Capitosti, T Antonucci, T Ellendorff, T Ishikawa, TB Emran, TC Lima, TC Yang, TES Ali, TP Yin, TR Burke, TS Tiuman, TT Cushnie, TW Sanchez, U Guzzi, U Singh, V Bhardwaj, V Exarchou, V Facchinetti, V Mihailovic, V Miliukienė, VK Bajpai, VV Kouznetsov, VV Kouznetsov, W He, X He, XD Wang, XJ Gao, XN Wang, XP Sun, Y Dai, Y Fang, Y Girard, Y Take, Y Tang, Y Zhao, Y Özkay, YH Seo, YLN Murthy, YM Sinam, Z Su   +215 more
core   +1 more source